BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,963,514 | -62.8% | 237,507 | -55.1% | 0.07% | -59.0% |
| Q2 2023 | $24,100,602 | -3.6% | 528,986 | -14.2% | 0.16% | +5.2% |
| Q1 2023 | $25,008,606 | -48.0% | 616,583 | -34.6% | 0.15% | -45.4% |
| Q4 2022 | $48,076,484 | +413.9% | 943,231 | +443.1% | 0.28% | +428.3% |
| Q3 2022 | $9,355,000 | -57.6% | 173,688 | -49.5% | 0.05% | -61.0% |
| Q2 2022 | $22,082,000 | -7.9% | 343,802 | +11.2% | 0.14% | -32.7% |
| Q1 2022 | $23,981,000 | +1428.4% | 309,273 | +1592.2% | 0.20% | +1246.7% |
| Q4 2021 | $1,569,000 | -59.6% | 18,276 | -62.1% | 0.02% | -69.4% |
| Q3 2021 | $3,880,000 | -83.6% | 48,241 | -83.6% | 0.05% | -81.6% |
| Q2 2021 | $23,727,000 | +107.7% | 294,746 | +117.6% | 0.27% | +82.9% |
| Q1 2021 | $11,425,000 | -4.8% | 135,466 | -9.5% | 0.15% | -11.5% |
| Q4 2020 | $12,006,000 | -37.1% | 149,631 | -37.0% | 0.16% | -41.7% |
| Q3 2020 | $19,092,000 | -3.6% | 237,409 | +3.3% | 0.28% | -17.3% |
| Q2 2020 | $19,797,000 | +2332.1% | 229,932 | +2193.1% | 0.34% | +1454.5% |
| Q1 2020 | $814,000 | -62.5% | 10,027 | -61.4% | 0.02% | -45.0% |
| Q4 2019 | $2,173,000 | -57.0% | 25,989 | -55.0% | 0.04% | -60.0% |
| Q3 2019 | $5,049,000 | -21.2% | 57,726 | -26.2% | 0.10% | -15.3% |
| Q2 2019 | $6,407,000 | +1795.6% | 78,229 | +1423.4% | 0.12% | +637.5% |
| Q4 2018 | $338,000 | -92.6% | 5,135 | -91.3% | 0.02% | -93.5% |
| Q3 2018 | $4,542,000 | +223.0% | 58,913 | +209.3% | 0.25% | +249.3% |
| Q2 2018 | $1,406,000 | -70.1% | 19,045 | -73.7% | 0.07% | -74.2% |
| Q1 2018 | $4,703,000 | +70.0% | 72,316 | +68.9% | 0.28% | +87.1% |
| Q4 2017 | $2,767,000 | +166.3% | 42,808 | +158.6% | 0.15% | +153.4% |
| Q3 2017 | $1,039,000 | +132.4% | 16,554 | +124.1% | 0.06% | +100.0% |
| Q2 2017 | $447,000 | +8.8% | 7,388 | -6.7% | 0.03% | 0.0% |
| Q1 2017 | $411,000 | -73.1% | 7,916 | -77.0% | 0.03% | -76.2% |
| Q4 2016 | $1,528,000 | +10814.3% | 34,456 | +11385.3% | 0.12% | +12100.0% |
| Q3 2016 | $14,000 | -98.9% | 300 | -98.9% | 0.00% | -98.6% |
| Q2 2016 | $1,270,000 | -4.8% | 28,086 | -13.5% | 0.07% | -2.6% |
| Q1 2016 | $1,334,000 | +2417.0% | 32,475 | +2233.0% | 0.08% | +2433.3% |
| Q4 2015 | $53,000 | -99.3% | 1,392 | -99.4% | 0.00% | -99.2% |
| Q3 2015 | $7,643,000 | +436.0% | 232,656 | +1040.6% | 0.39% | +451.4% |
| Q2 2015 | $1,426,000 | +3295.2% | 20,397 | +3195.2% | 0.07% | +3400.0% |
| Q1 2015 | $42,000 | -89.0% | 619 | -88.1% | 0.00% | -90.5% |
| Q4 2014 | $382,000 | -48.9% | 5,208 | -50.0% | 0.02% | -54.3% |
| Q3 2014 | $748,000 | -86.6% | 10,419 | -86.5% | 0.05% | -86.3% |
| Q2 2014 | $5,568,000 | – | 77,006 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |